Published in J Bacteriol on April 01, 2006
A conserved structural motif mediates formation of the periplasmic rings in the type III secretion system. Nat Struct Mol Biol (2009) 2.02
Protein export according to schedule: architecture, assembly, and regulation of type III secretion systems from plant- and animal-pathogenic bacteria. Microbiol Mol Biol Rev (2012) 1.92
Type III secretion systems shape up as they ship out. Curr Opin Microbiol (2009) 1.18
The RNA binding protein CsrA is a pleiotropic regulator of the locus of enterocyte effacement pathogenicity island of enteropathogenic Escherichia coli. Infect Immun (2009) 1.14
QseA and GrlR/GrlA regulation of the locus of enterocyte effacement genes in enterohemorrhagic Escherichia coli. J Bacteriol (2007) 1.10
Interactions between CdsD, CdsQ, and CdsL, three putative Chlamydophila pneumoniae type III secretion proteins. J Bacteriol (2008) 1.02
Bacterial macroscopic rope-like fibers with cytopathic and adhesive properties. J Biol Chem (2010) 1.00
Enteropathogenic Escherichia coli, Shigella flexneri, and Listeria monocytogenes recruit a junctional protein, zonula occludens-1, to actin tails and pedestals. Infect Immun (2006) 0.88
Role of EscP (Orf16) in injectisome biogenesis and regulation of type III protein secretion in enteropathogenic Escherichia coli. J Bacteriol (2012) 0.86
EscO, a functional and structural analog of the flagellar FliJ protein, is a positive regulator of EscN ATPase activity of the enteropathogenic Escherichia coli injectisome. J Bacteriol (2014) 0.81
Role of EscU auto-cleavage in promoting type III effector translocation into host cells by enteropathogenic Escherichia coli. BMC Microbiol (2011) 0.80
Structure and interactions of the cytoplasmic domain of the Yersinia type III secretion protein YscD. J Bacteriol (2012) 0.80
Type Three Secretion System in Attaching and Effacing Pathogens. Front Cell Infect Microbiol (2016) 0.79
The structure and specificity of the type III secretion system effector NleC suggest a DNA mimicry mechanism of substrate recognition. Biochemistry (2014) 0.78
Lambda Red-mediated Recombineering in the Attaching and Effacing Pathogen Escherichia albertii. Biol Proced Online (2016) 0.75
Functional Characterization of EscK (Orf4), a Sorting Platform Component of the Enteropathogenic Escherichia coli Injectisome. J Bacteriol (2016) 0.75
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol Mol Biol Rev (1998) 17.27
Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector. Infect Immun (1991) 15.39
Attaching and effacing activities of rabbit and human enteropathogenic Escherichia coli in pig and rabbit intestines. Infect Immun (1983) 12.81
A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc Natl Acad Sci U S A (1995) 12.79
Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell (1997) 9.60
Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation. Proc Natl Acad Sci U S A (1995) 6.59
Supramolecular structure of the Salmonella typhimurium type III protein secretion system. Science (1998) 6.55
Enteropathogenic Escherichia coli. Infect Immun (1992) 5.74
Dissecting virulence: systematic and functional analyses of a pathogenicity island. Proc Natl Acad Sci U S A (2004) 5.34
EspA, a protein secreted by enteropathogenic Escherichia coli, is required to induce signals in epithelial cells. Mol Microbiol (1996) 3.65
Structural insights into the assembly of the type III secretion needle complex. Science (2004) 3.49
Structure and composition of the Shigella flexneri "needle complex", a part of its type III secreton. Mol Microbiol (2001) 3.46
Molecular characterization and assembly of the needle complex of the Salmonella typhimurium type III protein secretion system. Proc Natl Acad Sci U S A (2000) 3.38
Contribution of Salmonella typhimurium type III secretion components to needle complex formation. Proc Natl Acad Sci U S A (2000) 3.10
The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles. Science (2005) 2.90
The outer membrane component, YscC, of the Yop secretion machinery of Yersinia enterocolitica forms a ring-shaped multimeric complex. Mol Microbiol (1997) 2.43
Supramolecular structure of the Shigella type III secretion machinery: the needle part is changeable in length and essential for delivery of effectors. EMBO J (2000) 2.39
Supermolecular structure of the enteropathogenic Escherichia coli type III secretion system and its direct interaction with the EspA-sheath-like structure. Proc Natl Acad Sci U S A (2001) 2.21
Structural characterization of the molecular platform for type III secretion system assembly. Nature (2005) 2.20
Mutational analysis of the Yersinia enterocolitica virC operon: characterization of yscE, F, G, I, J, K required for Yop secretion and yscH encoding YopR. Mol Microbiol (1995) 1.95
Secretin of the enteropathogenic Escherichia coli type III secretion system requires components of the type III apparatus for assembly and localization. Infect Immun (2003) 1.67
Enteropathogenic Escherichia coli activates the RhoA signaling pathway via the stimulation of GEF-H1. EMBO J (2004) 1.64
Mutations in yscC, yscD, and yscG prevent high-level expression and secretion of V antigen and Yops in Yersinia pestis. J Bacteriol (1995) 1.62
The filamentous type III secretion translocon of enteropathogenic Escherichia coli. Cell Microbiol (2001) 1.53
Structural characterization of a type III secretion system filament protein in complex with its chaperone. Nat Struct Mol Biol (2004) 1.37
Yeast two-hybrid system survey of interactions between LEE-encoded proteins of enteropathogenic Escherichia coli. Microbiology (2003) 1.34
MxiM and MxiJ, base elements of the Mxi-Spa type III secretion system of Shigella, interact with and stabilize the MxiD secretin in the cell envelope. J Bacteriol (2001) 1.26
Structure and electrophysiological properties of the YscC secretin from the type III secretion system of Yersinia enterocolitica. J Bacteriol (2004) 1.22
EPEC's weapons of mass subversion. Curr Opin Microbiol (2005) 1.20
Structure-function analysis of BfpB, a secretin-like protein encoded by the bundle-forming-pilus operon of enteropathogenic Escherichia coli. J Bacteriol (2001) 1.15
3D structure of EspA filaments from enteropathogenic Escherichia coli. Mol Microbiol (2003) 1.10
Structural and functional studies of the enteropathogenic Escherichia coli type III needle complex protein EscJ. Mol Microbiol (2005) 0.98
TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun (2006) 10.69
Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol (2008) 3.13
Formation of stress granules inhibits apoptosis by suppressing stress-responsive MAPK pathways. Nat Cell Biol (2008) 3.04
Prion-like spreading of pathological α-synuclein in brain. Brain (2013) 2.92
Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci Transl Med (2012) 2.80
The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells. Genes Cells (2005) 2.38
TDP-43 is deposited in the Guam parkinsonism-dementia complex brains. Brain (2007) 2.25
Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation. J Hepatol (2005) 2.01
Short fimbriae of Porphyromonas gingivalis and their role in coadhesion with Streptococcus gordonii. Infect Immun (2005) 1.91
Superoxide generation in directional coronary atherectomy specimens of patients with angina pectoris: important role of NAD(P)H oxidase. Arterioscler Thromb Vasc Biol (2002) 1.89
Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome. J Clin Endocrinol Metab (2006) 1.86
Microtubule-severing activity of Shigella is pivotal for intercellular spreading. Science (2006) 1.85
Abnormal phosphorylation of Ser409/410 of TDP-43 in FTLD-U and ALS. FEBS Lett (2008) 1.76
Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions. J Biol Chem (2002) 1.71
Targeting of the GTPase Irgm1 to the phagosomal membrane via PtdIns(3,4)P(2) and PtdIns(3,4,5)P(3) promotes immunity to mycobacteria. Nat Immunol (2009) 1.70
Small molecule inhibitors of alpha-synuclein filament assembly. Biochemistry (2006) 1.69
Enteropathogenic Escherichia coli activates the RhoA signaling pathway via the stimulation of GEF-H1. EMBO J (2004) 1.64
Targeting of enteropathogenic Escherichia coli EspF to host mitochondria is essential for bacterial pathogenesis: critical role of the 16th leucine residue in EspF. J Biol Chem (2004) 1.57
Emerging themes in IFN-gamma-induced macrophage immunity by the p47 and p65 GTPase families. Immunobiology (2007) 1.54
Analysis of the secondary structure of beta-amyloid (Abeta42) fibrils by systematic proline replacement. J Biol Chem (2004) 1.53
The ClpXP ATP-dependent protease regulates flagellum synthesis in Salmonella enterica serovar typhimurium. J Bacteriol (2002) 1.32
Conversion of wild-type alpha-synuclein into mutant-type fibrils and its propagation in the presence of A30P mutant. J Biol Chem (2009) 1.29
Shigella deliver an effector protein to trigger host microtubule destabilization, which promotes Rac1 activity and efficient bacterial internalization. EMBO J (2002) 1.27
Innovative preparation of curcumin for improved oral bioavailability. Biol Pharm Bull (2011) 1.26
Oxidative stress in the pathogenesis of thoracic aortic aneurysm: protective role of statin and angiotensin II type 1 receptor blocker. Cardiovasc Res (2003) 1.19
Methylene blue and dimebon inhibit aggregation of TDP-43 in cellular models. FEBS Lett (2009) 1.17
Sustained calpain activation associated with lysosomal rupture executes necrosis of the postischemic CA1 neurons in primates. Hippocampus (2003) 1.15
BopC is a novel type III effector secreted by Bordetella bronchiseptica and has a critical role in type III-dependent necrotic cell death. J Biol Chem (2006) 1.14
Identification of amino-terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration. Ann Neurol (2004) 1.13
Casein kinase 2 is the major enzyme in brain that phosphorylates Ser129 of human alpha-synuclein: Implication for alpha-synucleinopathies. FEBS Lett (2007) 1.12
Bordetella evades the host immune system by inducing IL-10 through a type III effector, BopN. J Exp Med (2009) 1.11
Cysteine misincorporation in bacterially expressed human alpha-synuclein. FEBS Lett (2006) 1.10
Identification of casein kinase-1 phosphorylation sites on TDP-43. Biochem Biophys Res Commun (2009) 1.09
Pathological alpha-synuclein propagates through neural networks. Acta Neuropathol Commun (2014) 1.09
Membrane binding properties and terminal residues of the mature hepatitis C virus capsid protein in insect cells. J Virol (2004) 1.08
Guadinomines, Type III secretion system inhibitors, produced by Streptomyces sp. K01-0509. I: taxonomy, fermentation, isolation and biological properties. J Antibiot (Tokyo) (2008) 1.07
A pilot approach for quantitative assessment of liver fibrosis using ultrasound: preliminary results in 79 cases. J Hepatol (2005) 1.07
Mast cell-mediated immune responses through IgE antibody and Toll-like receptor 4 by malarial peroxiredoxin. Eur J Immunol (2008) 1.06
Analyses of the MAPT, PGRN, and C9orf72 mutations in Japanese patients with FTLD, PSP, and CBS. Parkinsonism Relat Disord (2012) 1.05
Enteropathogenic Escherichia coli type III effectors EspG and EspG2 alter epithelial paracellular permeability. Infect Immun (2005) 1.04
Increased serum concentrations of pigment epithelium-derived factor in patients with end-stage renal disease. Clin Chem (2006) 1.03
C-Jun N-terminal kinase controls TDP-43 accumulation in stress granules induced by oxidative stress. Mol Neurodegener (2011) 1.01
Interference with BRCA2, which localizes to the centrosome during S and early M phase, leads to abnormal nuclear division. Biochem Biophys Res Commun (2007) 1.01
Interaction of antiproliferative protein Tob with the CCR4-NOT deadenylase complex. Cancer Sci (2008) 1.01
Inhibition of alpha-synuclein fibril assembly by small molecules: analysis using epitope-specific antibodies. FEBS Lett (2009) 1.00
Shigella-induced necrosis and apoptosis of U937 cells and J774 macrophages. Microbiology (2003) 1.00
Sorting nexin 27 interacts with multidrug resistance-associated protein 4 (MRP4) and mediates internalization of MRP4. J Biol Chem (2012) 0.99
Restraint stress delays solid gastric emptying via a central CRF and peripheral sympathetic neuron in rats. Am J Physiol Regul Integr Comp Physiol (2004) 0.99
Novel antiangiogenic pathway of thrombospondin-1 mediated by suppression of the cell cycle. Cancer Sci (2007) 0.99
Factors predicting the presence of small bowel lesions in patients with obscure gastrointestinal bleeding. Dig Endosc (2012) 0.98
Restraint stress stimulates colonic motility via central corticotropin-releasing factor and peripheral 5-HT3 receptors in conscious rats. Am J Physiol Gastrointest Liver Physiol (2006) 0.98
Methylene blue reduced abnormal tau accumulation in P301L tau transgenic mice. PLoS One (2012) 0.98
Phosphatidylinositol 4-phosphate 5-kinase alpha (PIPKα) regulates neuronal microtubule depolymerase kinesin, KIF2A and suppresses elongation of axon branches. Proc Natl Acad Sci U S A (2012) 0.98
BopB is a type III secreted protein in Bordetella bronchiseptica and is required for cytotoxicity against cultured mammalian cells. Cell Microbiol (2003) 0.97
Phosphorylation of measles virus nucleoprotein upregulates the transcriptional activity of minigenomic RNA. Proteomics (2008) 0.96
Fibulin-4 is a target of autoimmunity predominantly in patients with osteoarthritis. J Immunol (2006) 0.96
Immunohistochemical metallothionein expression in hepatocellular carcinoma: relation to tumor progression and chemoresistance to platinum agents. J Gastroenterol (2004) 0.96
Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation of hepatocellular carcinoma by three-dimensional sonography with a perflubutane-based contrast agent. Eur J Radiol (2009) 0.96
Extensive deamidation at asparagine residue 279 accounts for weak immunoreactivity of tau with RD4 antibody in Alzheimer's disease brain. Acta Neuropathol Commun (2013) 0.95
Differential expression of type III effector BteA protein due to IS481 insertion in Bordetella pertussis. PLoS One (2011) 0.94
Synergic effect of genotype changes in pertussis toxin and pertactin on adaptation to an acellular pertussis vaccine in the murine intranasal challenge model. Clin Vaccine Immunol (2010) 0.93
Similarities of the neuronal circuit for the induction of fictive vomiting between ferrets and dogs. Auton Neurosci (2007) 0.93
Cleavage of nonmuscle myosin heavy chain-A during apoptosis in human Jurkat T cells. J Biochem (2005) 0.92
Digital image processing of laryngeal lesions by electronic videoendoscopy. Laryngoscope (2002) 0.90
Contrast-enhanced three-dimensional fusion sonography of small liver metastases with pathologic correlation. J Clin Ultrasound (2007) 0.90
The type III secreted protein BopD in Bordetella bronchiseptica is complexed with BopB for pore formation on the host plasma membrane. J Bacteriol (2004) 0.90
Metal contents in the liver of patients with chronic liver disease caused by hepatitis C virus. Reference to hepatocellular carcinoma. Oncology (2003) 0.90
Isoaspartate formation at position 23 of amyloid beta peptide enhanced fibril formation and deposited onto senile plaques and vascular amyloids in Alzheimer's disease. J Neurosci Res (2002) 0.90
A small-molecule inhibitor of the bacterial type III secretion system protects against in vivo infection with Citrobacter rodentium. J Antibiot (Tokyo) (2010) 0.90
Characterization of the interaction between DNA gyrase inhibitor and DNA gyrase of Escherichia coli. J Biol Chem (2002) 0.89
Molecular dissection of TDP-43 proteinopathies. J Mol Neurosci (2011) 0.89
Molecular analysis and biochemical classification of TDP-43 proteinopathy. Brain (2012) 0.89
Nocardioides aromaticivorans sp. nov., a dibenzofuran-degrading bacterium isolated from dioxin-polluted environments. Syst Appl Microbiol (2005) 0.89
Carbonic anhydrase II is a tumor vessel endothelium-associated antigen targeted by dendritic cell therapy. Clin Cancer Res (2005) 0.89
Establishment of a binding assay for protein kinase C isozymes using synthetic C1 peptides and development of new medicinal leads with protein kinase C isozyme and C1 domain selectivity. Pharmacol Ther (2002) 0.89
Effects of acupuncture on vasopressin-induced emesis in conscious dogs. Am J Physiol Regul Integr Comp Physiol (2004) 0.89
Enniatin has a new function as an inhibitor of Pdr5p, one of the ABC transporters in Saccharomyces cerevisiae. Biochem Biophys Res Commun (2005) 0.89
Assessment of cancer cell differentiation in small hepatocellular carcinoma by computed tomography and magnetic resonance imaging. J Gastroenterol Hepatol (2003) 0.89
Neuronal and glial inclusions in frontotemporal dementia with or without motor neuron disease are immunopositive for p62. Neurosci Lett (2003) 0.88
Guadinomines, Type III secretion system inhibitors, produced by Streptomyces sp. K01-0509. II: physico-chemical properties and structure elucidation. J Antibiot (Tokyo) (2008) 0.88
In vivo modifications of small GTPase Rac and Cdc42 by Bordetella dermonecrotic toxin. Infect Immun (2002) 0.88